You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

insulin aspart

Showing 1 - 25 of 8,111
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes Trial (Insulin Degludec and Insulin Aspart)

Not yet recruiting
  • Diabetes
  • Insulin Degludec and Insulin Aspart
  • (no location specified)
Apr 4, 2023

Diabetes, Type 1 Trial in Manchester (FIASP + closed loop device, Insulin aspart (standard of care insulin) + closed loop

Completed
  • Diabetes Mellitus, Type 1
  • FIASP + closed loop device
  • Insulin aspart (standard of care insulin) + closed loop device
  • Manchester, United Kingdom
    Manchester University Hospitals NHS Foundation Trust
Aug 19, 2022

Pharmacokinetics, Pharmacodynamics Trial in Chula Vista (I004, NovoLog)

Recruiting
  • Pharmacokinetics
  • Pharmacodynamics
  • Chula Vista, California
    Amphastar Study Site
Sep 13, 2022

Diabetes, Type 2 Trial in Graz (AT278, NovoRapid, Humulin R 500 UNT/ML Injectable Solution)

Recruiting
  • Diabetes Mellitus, Type 2
  • Graz, Austria
    Clinical Trials Unit, Medical University of Graz
Mar 3, 2023

Type 2 Diabetes Trial in China (Insulin Degludec and Insulin Aspart Injection, Insulin Aspart Injection)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Insulin Degludec and Insulin Aspart Injection
  • Insulin Aspart Injection
  • Shijiazhuang, Hebei, China
  • +5 more
Jun 13, 2022

Type 1 Diabetes Trial in Cambridge (CamAPS FX using faster insulin aspart, CamAPS FX using standard insulin aspart)

Active, not recruiting
  • Type 1 Diabetes Mellitus
  • CamAPS FX using faster insulin aspart
  • CamAPS FX using standard insulin aspart
  • Cambridge, Cambridgeshire, United Kingdom
  • +1 more
Nov 9, 2022

Insulin Pump,Continuous Glucose Monitoring Technology Trial in Guandong (Insulin Glargine, Metformin, Dapagliflozin)

Recruiting
  • Insulin Pump，Continuous Glucose Monitoring Technology
  • Insulin Glargine
  • +3 more
  • Guandong, China
    刘烈华
Nov 7, 2023

Diabetes Trial in Chengdu (INS062 injection, Insulin Aspart, HR20014 injection)

Recruiting
  • Diabetes
  • INS062 injection
  • +3 more
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Feb 8, 2023

Gestational Diabetes, Oxidative Stress, Vascular Endothelial Function Trial (Acetylcholine, Insulin aspart)

Not yet recruiting
  • Gestational Diabetes
  • +2 more
  • (no location specified)
Jul 7, 2023

Type 1 Diabetes Trial in Montréal (Insulin FiAsp, Insulin Aspart, 60-minutes postprandial exercise)

Recruiting
  • Type 1 Diabetes Mellitus
  • Insulin FiAsp
  • +3 more
  • Montréal, Quebec, Canada
    Institut de recherches cliniques de Montréal
Mar 8, 2022

Diabetes, Type 1, Diabetes, Type 2 Trial in China (Faster aspart, Insulin aspart, Insulin degludec)

Completed
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Faster aspart
  • +2 more
  • Hefei, Anhui, China
  • +34 more
Nov 3, 2022

type1diabetes, Diabetes, Type 1 Trial in Montreal (Pramlintide, Insulin Lispro, Insulin aspart)

Not yet recruiting
  • type1diabetes
  • Diabetes Mellitus, Type 1
  • Montreal, Quebec, Canada
    Research Institute of the McGill University Health Center
Sep 18, 2023

Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)

Recruiting
  • Diabetes Mellitus, Type 2 Treated With Insulin
  • insulin degludec + liraglutide
  • Insulin Glargine - Insulin Aspart
  • Bogotá, Colombia
    Hospital Universitario San Ignacio
Mar 2, 2023

Liver Cirrhosis, Diabetes Trial in Shanghai (Insulin Degludec and Insulin Aspart)

Recruiting
  • Liver Cirrhosis
  • Diabetes
  • Insulin Degludec and Insulin Aspart
  • Shanghai, Shanghai, China
    Xiaolong Zhao
Nov 29, 2022

Gestational Diabetes, Vascular Endothelial Function Trial in Iowa City (Acetylcholine, insulin aspart)

Recruiting
  • Gestational Diabetes
  • Vascular Endothelial Function
  • Iowa City, Iowa
    University of Iowa
Jul 7, 2023

Type 2 Diabetes, Postprandial Hyperglycemia Trial in Stockholm (Insulin aspart (Novorapid®))

Completed
  • Type 2 Diabetes Mellitus
  • Postprandial Hyperglycemia
  • Insulin aspart (Novorapid®)
  • Stockholm, Sweden
    Department of Medicine, Clinical pharmacology Unit, Karolinska U
May 24, 2022

Type 2 Diabetes Trial in South Miami (Insulin Glargine, Insulin Aspart, Insulin Lispro)

Terminated
  • Type 2 Diabetes Mellitus
  • Insulin Glargine
  • +2 more
  • South Miami, Florida
    University of Miami
Aug 18, 2022

Type 2 Diabetes Trial in Graz (Insulin Aspart, Insulin Aspart 30, Insulin Aspart 70)

Completed
Has Results
  • Type 2 Diabetes
  • Insulin Aspart
  • +2 more
  • Graz, Austria
    Medical University of Graz, Department for Internal Medicine
Jun 9, 2021

Type 1 Diabetes Trial in Little Rock, Denver, West Des Moines (Insulin aspart SAR341402, Insulin aspart)

Completed
  • Type 1 Diabetes Mellitus
  • Insulin aspart SAR341402
  • Insulin aspart
  • Little Rock, Arkansas
  • +2 more
Apr 21, 2022

Type 2 Diabetes Trial in Chicago (insulin aspart, insulin detemir)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • insulin aspart
  • insulin detemir
  • Chicago, Illinois
    Rush University Medical Center
Jan 31, 2022

Diabetes, Type 1 Trial in Aurora (Technosphere insulin)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Technosphere insulin
  • Aurora, Colorado
    Barbara Davis Center
Jan 28, 2022

Insulin, Exercise Trial in East Lansing (Placebo into the intranasal mucosa, 20 IU NovoLog Insulin aspart into the intranasal

Completed
Has Results
  • Insulin
  • Exercise
  • Placebo into the intranasal mucosa
  • +6 more
  • East Lansing, Michigan
    Department of Kinesiology
May 27, 2021

Diabetes, Type 1, Diabetes, Type 2 Trial in Shatin, New Territories (Faster Aspart, Novo Rapid)

Recruiting
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Faster Aspart
  • Novo Rapid
  • Shatin, New Territories, Hong Kong
    Novo Nordisk Investigational Site
Jun 23, 2022

Diabetes, Type 1 Trial in Palo Alto (Fiasp, Novolog)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Palo Alto, California
  • +1 more
Aug 16, 2021

Type 2 Diabetes Trial in Cleveland (Semaglutide, Insulin Degludec, Insulin aspart)

Recruiting
  • Type 2 Diabetes
  • Cleveland, Ohio
    Cleveland Clinic
Jul 18, 2022